Vivos Therapeutics acquires stake in SOD Sciences in stock-only deal Oct 19, 2026 05:02PM
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel Oct 19, 2026 05:01PM